Boehringer Ingelheim Vetmedica Launches Buscopan® 20

Boehringer Ingelheim Vetmedica has launched Buscopan® 20mg/ml injection, an antispasmodic treatment for use in cases of equine colic, and an aid to the symptomatic treatment of calf scour. A sister product to Buscopan® Compositum which contains both an antispasmodic and a non-steroidal component, Buscopan 20 contains only the antispasmodic component – hyoscine butylbromide. “Our customers have been telling us for some time that they would really welcome a Buscopan formulation without an NSAID for use in horses and cattle,” says Craig Beck, equine sales and marketing manager at Boehringer Ingelheim Vetmedica. “I’m pleased to say that it’s finally here and I’m sure that Buscopan 20 will be a very welcome addition to the armoury of both equine and cattle practitioners.” Buscopan 20 is supplied in a convenient 50ml multi-dose bottle, and is available in veterinary wholesalers now. For further information, please call 01344 746959.

More from

• 'Tax changes could land your practice with someone else's bills', warns vet founder
• Pet Health Clubs' fight for survival remains unresolved
• How a teenage James Herriot moved from clinic to boardroom
• Frustration to innovation: The shaping of transformative hiring platform
• Animus launches SkinBond Multi for enhanced wound care